Case Series of Peroneal Nerve Palsy from Leg Crossing after Tirzepatide Weight Loss

A 2026 case report from figshare details two male patients who developed foot drop following tirzepatide-induced weight loss. The 1.7 MB PDF document describes patient histories, weight loss amounts, symptom onset, and treatment outcomes. It was authored by figshare admin karger and is licensed under CC-BY-4.0.

Use Cases

• Analyzing risk factors for peroneal nerve palsy based on descriptions of rapid weight loss and leg crossing.
• Studying treatment outcomes for 'Slimmer's Palsy' based on behavioral modification and physical therapy details.
• Investigating the timeline of symptom resolution based on the reported three to four month recovery period.

Strengths

• Includes specific patient details such as age, weight loss amounts (50 and 30 pounds), and treatment timelines.
• Provides a clear clinical narrative with documented outcomes over a three to four month period.
• The source file is a 1.7 MB PDF, suggesting a detailed, document-based case report.

Limitations

• Row count is unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.
• The dataset is a single case report PDF, limiting statistical analysis.

Provenance

Source

figshare

Collection Method

Clinical case report documentation.

Freshness

Last updated 2026-06-04 05:55:12; freshness should be verified.